| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.360 | 10.684 | 10.905 | 9.807 | 9.164 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 9.360 | 10.684 | 10.905 | 9.807 | 9.164 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 10.205 | 3.622 | 9.532 | 7.633 | 8.865 | 4.543 | 6.765 | 6.202 | 8.009 | 8.310 |
| Gross Profit/Loss - EUR | -845 | 7.062 | 1.373 | 2.174 | 298 | -4.543 | -6.765 | -6.202 | -8.009 | -8.310 |
| Net Profit/Loss - EUR | -1.128 | 6.763 | 1.160 | 1.931 | 23 | -4.543 | -6.765 | -6.202 | -8.009 | -8.310 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Ortosib Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 231 | 229 | 238 | 221 | 37.226 | 35.073 | 32.130 | 30.389 | 29.276 | 26.824 |
| Current Assets | 5.167 | 10.211 | 8.999 | 15.678 | 7.347 | 7.578 | 3.243 | 4.164 | 2.115 | 2.344 |
| Inventories | 2.383 | 2.780 | 701 | 1.014 | 1.716 | 1.762 | 1.755 | 1.760 | 1.755 | 1.745 |
| Receivables | 2.318 | 2.276 | 1.125 | 9.435 | 5.624 | 5.806 | 0 | 1.534 | 0 | 446 |
| Cash | 466 | 5.155 | 7.173 | 5.229 | 7 | 10 | 1.487 | 869 | 360 | 153 |
| Shareholders Funds | -30 | 6.733 | 7.779 | 9.567 | 9.405 | 4.638 | -2.230 | -8.438 | -16.422 | -24.639 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 5.429 | 3.707 | 1.457 | 6.332 | 35.168 | 38.013 | 37.602 | 42.991 | 47.813 | 53.808 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Ortosib Srl